Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0779 per EA under NDC 68001061303. Its NADAC has been published 114 times since Apr 24, 2024.
Strength
150 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001061303
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215568On Market Since
4/8/2024
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 114 times since Apr 24, 2024, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0779 per EA |
|---|---|
| All-time high | $0.1131 (Jul 10, 2024) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1042 |
| 52-week low | $0.0770 |
| Median price | $0.0996 |
| Average price | $0.0956 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 114 |
| Tracking since | Apr 24, 2024 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by BluePoint Laboratories, is $0.0779 per EA (NDC 68001061303), effective Jun 24, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 24.5%. It has been tracked across 114 weekly CMS publications since Apr 24, 2024.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Apr 24, 2024, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1131 (Jul 10, 2024), with a median of $0.0996 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as BUPROPION HCL XL 150 MG TABLET, but none are currently priced below it.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 68001061303) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification